Metastasis-free survival (MFS) may not have the same meaning after radical prostatectomy (RP) and radiotherapy (RT), largely because RT is typically combined with prolonged androgen-deprivation therapy (ADT), which can delay the clinical emergence of metastases. Therefore, MFS benefits cannot be assumed to have the sam...
M. Baboudjian, Alessandro Uleri, G. Fallara et al.· European Urology Oncology· 0 citations
The aim of this review was to summarize current evidence on AI-based imaging analysis, radiomics, and pathomics for PCa detection, characterization, risk stratification, and pathological assessment, while highlighting the methodological challenges that currently limit clinical implementation.
R. Rahota, Andrei-Vlad Bădulescu, B. Buhas et al.· Journal of Clinical Medicine· 0 citations
Growing evidence suggests that AS appears oncologically safe in well-selected patients, and magnetic resonance imaging will play a key role in the appropriate selection and follow-up of patients.
Alessandro Uleri, L. Cella, T. Long-Depaquit et al.· BJU International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
